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An increased risk of serious bacterial infections in HIV-exposed uninfected (HEU) infants 
has been demonstrated. Although neutrophils are essential for the protection of infants 
against bacterial infections, no study has investigated their profile in HEU infants to date. 
In this study, we assessed the function of neutrophils in HEU infants using the nitroblue 
tetrazolium reduction test. Among 25 HEU infants, 9 (36%) showed a reduced ability of 
their neutrophils to produce reactive oxygen species upon stimulation with bacteria. No 
alteration of total neutrophil counts was noted in the blood of HEU infants indicating that 
the alteration observed in the 36% of HEU infants may only be functional. Conclusively, 
impaired neutrophil function could be a factor of vulnerability in HEU infants.
Keywords: hiV, neutrophils, reactive oxygen species, nitroblue tetrazolium, infants
inTrODUcTiOn
The implementation of mother-to-child transmission prevention programs worldwide is arguably 
one of the major public health successes of the present century. Indeed, the proposed recommenda-
tions on the antiretroviral therapy on mothers and their infants, together with improved obstetric 
management and the updated protocols on breastfeeding from HIV-infected mothers have consider-
ably reduced the number of infected infants in developing countries (1, 2).
Currently, it is estimated that HIV-exposed uninfected (HEU) infants represent up to 30% of 
all births in Africa (3, 4). Although mother-to-child transmission prevention programs have dra-
matically reduced the mother-to-child transmission rate, HEU infants are still more vulnerable to 
infections when compared to HIV-unexposed (HU) infants from HIV-uninfected mothers. This was 
robustly demonstrated in a study conducted in Zimbabwe between 1987 and 2000, where more than 
14,000 participants were enrolled (5). In this study, an elevated mortality rate of HEU infants was 
observed (5). The 2-year mortality rate was three times higher in the HEU cohort when compared 
to the HU cohort (5, 6). Morbidity and mortality were at their peak levels in the 3–6 months old 
children, and the majority of the deaths were associated to lower respiratory tract infections. This 
seminal observation has been supported by several other studies in Africa that have independently 
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reported a more vulnerable immune system thus a higher risk of 
infection of HEU infants when compared to HU infants (7–13).
Intensive research on HIV and antiretroviral (ARV)-drug 
therapy has improved our understanding of the immune sus-
ceptibility of HIV-infected population (14–16); however, our 
understanding of HIV/therapy exposure on HEU infants is still 
limited. A number of studies have reported a lower numbers of 
naive CD4+ cells, a reduced thymic output (17) and an impaired 
humoral response to vaccines (18) in HEU infants. However, the 
vulnerability of the immune system of HEU infants in the context 
of the alteration of the production of reactive oxygen species 
(ROS), a class of signaling molecules that regulate many signal-
transduction pathways and play critical roles in cell survival, 
death, and immune defenses during infection (15, 19) has never 
been addressed.
Neutrophils are major producers of ROS and essential effector 
cells of the innate immune response against invading pathogens 
and the pivots of innate immunity; as they are first and powerful 
defense system against invading pathogens (20). Microbicides 
and cytotoxic activities of neutrophils depend on very intricate 
mechanisms including the release of proteolytic enzymes and the 
rapid production of ROS (oxidative burst) (21). The respiratory 
burst is the major mechanism by which neutrophils kill engulfed 
bacteria (22). In the light of the foregoing and of the observed 
susceptibility of HEU infants to infections, we investigated the 
phagocytes oxidative capacity of HEU infants.
MaTerials anD MeThODs
Participants
Twenty-five healthy HEU infants aged 6- to 12-week olds visiting 
the National Laboratory of Public Health in Libreville (Gabon) 
were prospectively recruited from March to August 2015. The 
mothers and infants information on preventive treatment, 
breastfeeding, time of anti-viral therapy initiation were recorded.
HIV perinatal infection (RT-PCR Cobas, Biomerieux, France) 
were checked from each HEU infant in peripheral blood at 1.5, 
3, 6, and 9 months after birth as part of their scheduled checked 
up in the reference laboratory in Gabon. An additional sample 
was taken to determine anti-HIV-1 antibodies seroconversion by 
ELISA at 18 months old. All HIV-positive infants and infants with 
any clinical condition at the time of recruitment were excluded 
from the study.
ethics statement
Informed consent was obtained from parents of all study partici-
pants. The National Laboratory of Public Health Ethics Review 
Board of Gabon approved the protocol. We adhered to the World 
Medical Association’s Declaration of Helsinki and Good Clinical 
Practice guidelines during the treatment of all participants and 
handling of their personal data.
neutrophils Oxidative Burst response 
assay
The neutrophils oxidative burst response was performed on 
blood collected from 6- or 12-week-old infants using the In 
vitro diagnostic quality Sigma-Aldrich nitroblue tetrazolium 
(NBT) reduction test (St. Louis, MO, USA). The test was done 
according to the manufacturer protocol. Briefly, venous blood 
from infants was drawn into a heparin tube. Heparinized blood 
(0.05–0.2 ml) was mixed with the NBT mixture (1–1.2 ml) and 
5 μl of stimulant (bacterial extracts/endotoxins) in the stimulated 
samples. Fifty microliters of heparinized blood–NBT mixture 
were transferred onto a clean glass slide to make a moderately 
thick smear. The smears were treated with 1 ml of ACCUSTAIN 
Wright Stain for 15 s and flooded with 1 ml of distilled water for 
30 s, rinsed and air-dried. Three readers evaluated the percent-
age of formazan-containing neutrophils on stained slides under 
a microscope.
interpretation nBT reduction Test  
results
According to the literature, 69–100% of resting neutrophils are 
NBT-positive in healthy newborn infants (23). In the present 
study, we set the threshold for the diagnosis of oxidative burst 
defect at 60% of neutrophils reducing NBT after bacterial 
extracts stimulation. Therefore, neutrophils function was 
defined as normal if more than 60% of neutrophils reduced 
NBT after bacterial extracts stimulation. Impaired or reduced 
ROS production was evoked when a subject shows less than 
60% of neutrophils reducing NBT after bacterial extracts 
stimulation.
statistical analysis
All statistical analyses were done using the software GraphPad 
Prism version 6. Descriptive statistics and odds ratios were used 
to characterize the study population. The difference between 
infants with neutrophils dysfunction and infants with functional 
neutrophils was assessed using the Mann–Whitney U-test (sig-
nificance set p-value ≤0.05).
resUlTs anD DiscUssiOn
Infections in infants are an important cause of morbidity and 
mortality. Understanding their immune system is crucial to 
develop new approaches to fight and prevent diseases and improve 
their health. Because in their early life, infants depend mainly on 
their innate immune system for protection against infections, we 
studied HEU infants’ neutrophils function.
Neutrophils oxidative burst was assessed for 25 HIV-exposed 
infants referred to our study site; The National Laboratory of 
Public Health (Libreville, Gabon). This study focused in HEU 
infants as the HU infants are not follow-up in our study site. 
It was therefore difficult to include HU children in this pilot 
study. Nevertheless, we manage to include three HU infants in 
the study. Their results are included in the study as technical 
control. The limited number of HU (3  HU infants) obtained 
in this study was not enough for experimental control. Their 
immune responses were not directly compared to HEU immune 
response. ROS are crucially involved in microbial killing (22, 24). 
Figure 1 illustrates the quantification of NBT-test negative and 
positive neutrophils. Seventeen of the twenty-five infants were 
males and eight were females as shown in the Table 1. Sixteen 
FigUre 1 | Photomicrographs of nitroblue tetrazolium (nBT) dye reduction by blood neutrophils from heU infants (at ×100 magnification). 
Positive = neutrophils contain increased formazan deposits visible as a large dark purple to black intra-cytoplasmic inclusions (a). Negative = neutrophils contain 
few or no formazan deposits (B).
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HIV-exposed infants (64%) had normal neutrophils profile after 
antigen stimulation. In those infants, the rate of neutrophils posi-
tive for formazan deposits (reduced NBT) after bacterial extracts 
stimulation ranged from 67 to 97.7% (Table 1). We observed a 
high number of resting neutrophils producing ROS (reducing 
NBT) in most HEU infants with functioning neutrophils. This 
observation was not surprising, as an increased reduction of NBT 
by neutrophils of newborn infants has already been reported 
(23, 25). Tovo and Ponzone illustrated the presence of humoral 
factors stimulating ROS secretion by neutrophils leading to 
positive NBT reduction (25) in the plasma of neonates. The high 
percentages of NBT positive cells could also be explained by 
in utero exposure to a pro-inflammatory fetal environment (26). 
Figure 2 shows selected HEU infants ROS secretion profile after 
antigen stimulation.
Nine HIV-exposed infants (36%) showed impaired ROS 
production after stimulation with bacterial extracts (Table 1). In 
those infants, the rate of neutrophils positive for formazan depos-
its after bacterial extracts stimulation ranged from 3 to 35%. The 
ability of neutrophil to produce ROS after exposure to bacteria 
or bacteria extracts indicates the functionality of these immune 
cells. Several studies have addressed the alteration of the neutro-
phil compartment in HEU infants. A telling example is that of 
an European collaborative study which reported that exposure to 
ARV does not affects HEU children neutrophils count during the 
first months of life (27). This is consistent with our present data 
and further reinforces the notion that neutrophil counts might 
not be a reliable early indicator of the defective immune system 
of HEU infants.
Our study does not only assess the number of neutrophils 
but beyond the quantitative appraisal of these important innate 
immune effector cells, also looks at their functionality in the 
form of ROS secretion. We report an impaired production of 
ROS by neutrophils of 36% of HEU infants suggestive of an 
impaired immune system in these infants. This finding is clearly 
important but would urgently require to be validated in a larger 
study. Given the small number, the primary results presented in 
this study could be a call to the scientific community to further 
investigate early marker(s) of immune dysfunction in HEU 
infants.
The metabolic defect observed in a number of HEU infants 
could find its explanations by the transfer of immunosuppres-
sive viral products across the placenta that has been suggested 
to suppress infants’ immune system without productive infec-
tion (4). Moreover, antenatal ARV-prophylaxis therapy for the 
prevention of mother-to-child transmission has been reported to 
TaBle 1 | nitroblue tetrazolium (nBT)-test results and clinical information.
infant iD age (in 
weeks)
gender nBT-positive neutrophils interpretation infants preventive Thx Breastfeeding Mother start of antiretroviral therapy
non-
stimulated 
(%)
stimulated 
(%)
Before 
pregnancy
During pregnancy Therapy
HEU1 10 Male 86.7 88 Normal neutrophils Nevirapine/co-trimoxazole No No Yes @ 6 months EFV-TDF-LVD
HEU2 6 Male 60 89 Normal neutrophils Nevirapine/co-trimoxazole No Yes No TDF-3TC-EFV
HEU3 12 Female 75 85 Normal neutrophils Zidovidine/co-trimoxazole No Yes No 3TC-Zido-EFV
HEU4 6 Female 73 85 Normal neutrophils Yes No TDF-3TC-EFV
HEU5 12 Female 47 92.7 Normal neutrophils Zidovidine/co-trimoxazole No Yes No
HEU6 6 Male 78 91 Normal neutrophils Nevirapine/co-trimoxazole No Yes No
heU7 6 Female 9.3 12.7 Impaired reactive oxygen species 
(ROS) production
nevirapine/co-trimoxazole no no no none
heU8 10 Male 8.7 4.7 Impaired ROS production nevirapine/co-trimoxazole no no Yes @ 4 months TDF-FTc-eFV
heU9 10 Male 9.5 7 Impaired ROS production nevirapine/co-trimoxazole no no Yes @ 4 months TDF-FTc-eFV
heU10 6 Male 14 35 Impaired ROS production nevirapine no Yes nO
heU11 6 Female 48.3 38 Impaired ROS production nevirapine/co-trimoxazole no no Yes @ 6 months
heU12 6 Male 37 34 Impaired ROS production nevirapine/co-trimoxazole no no Yes @ 2 months
HEU13 6 Female 6.3 97.7 Normal neutrophils Nevirapine/co-trimoxazole No Yes ABC-3TC-LPV-
RTV
heU14 12 Male 14 23 Impaired ROS production nevirapine/co-trimoxazole Yes (for 
3 months)
no Yes @ 6 months TDF-3Tc-eFV
HEU15 6 Male 93.7 94.7 Normal neutrophils NO Yes No Yes @ 3 months TDF-FTC-EFV
HEU16 6 Male 91.7 98 Normal neutrophils Nevirapine/co-trimoxazole No Yes No
HEU17 8 Male 96 99 Normal neutrophils Nevirapine No No Yes @ 3 months TDF-FTC-EFV
HEU18 7 Male 75 81.3 Normal neutrophils Nevirapine/co-trimoxazole No Yes @ 4 months
HEU19 6 Female 74.7 73.3 Normal neutrophils Nevirapine/co-trimoxazole No No Yes @ 4 months
HEU20 6 Male 86 88 Normal neutrophils Nevirapine/co-trimoxazole No Yes No
heU21 6 Female 33.3 30.5 Impaired ROS production nevirapine/co-trimoxazole no Yes no
heU22 6 Male 3 3 Impaired ROS production nevirapine/co-trimoxazole no Yes no TDF-3Tc-eFV
HEU23 6 Male 74.7 67 Normal neutrophils Nevirapine/co-trimoxazole No Yes No
HEU24 6 Male 67 80 Normal neutrophils Nevirapine/co-trimoxazole No Yes No AZT-3TC-NVP
HEU25 6 Male 74 83.7 Normal neutrophils Nevirapine/co-trimoxazole No No Yes @ 7 months AZT-3TC-NVP
HU1 12 Female 56 72.7 Normal neutrophils NA NA NA NA NA
HU2 8 Female 53 92 Normal neutrophils NA NA NA NA NA
HU3 6 Male 76.3 95.3 Normal neutrophils NA NA NA NA NA
Bold font indicates Impaired ROS production.
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FigUre 2 | Photomicrographs of nitroblue tetrazolium (nBT) dye reduction profiles of selected hiV-exposed uninfected (heU) infants blood 
neutrophils (at ×100 magnification). Reactive oxygen species (ROS)− HEU infants indicate infants with impaired ROS production. ROS+ HEU infants indicate 
infants with normal ROS production. ROS+ HEU infants illustrated by HEU 17, 16, and 27 showed increased formazan deposits visible as a large dark purple to 
black intra-cytoplasmic inclusions whereas, ROS− HEU infants illustrated by HEU 8, 9, and 22 showed few or no formazan deposits.
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be toxic to mitochondria and to modulate the immune system 
of HEU infants (4). This was further suggested experimentally 
by Michailidis et  al., who showed that neutrophil oxidative 
burst was significantly lower in HIV-patients receiving highly 
active anti-retroviral treatment (HAART) when compared to 
treatment-naïve patients, supporting the plausible link between 
HAART and neutrophils impaired oxidative burst (28). We now 
provide additional evidences for such a link as our contingency 
table analysis showed that infants born from mothers who started 
ARV-therapy during pregnancy had an odds ratio of 2.8 for oxi-
dative burst defect when compared to infants born from mothers 
who started ARV-therapy before pregnancy. Although suggestive, 
our present findings need to be validated in larger studies for 
dispositive answers on the role of ARV and/or HIV in utero HIV 
exposure on the neutrophil functions and the relationship of this 
apparent interdependence on the impaired immune system of 
HEU infants.
We believe that the observed impaired function of neutrophils 
in HEU infants to be transient. In fact, a couple of HEU infants 
who had impaired neutrophils function and that was brought 
for an unscheduled visit 2  months after the recruitment had 
recovered neutrophils function (data not shown). This is not 
surprising as Le Chenadec et al. reported that ARV exposure had 
a transient effect on several selected hematological variables in 
HEU infants (29).
Comparing the blood of infants with dysfunction neutrophil 
function with that of infants with unaltered responsiveness, 
we found no significant differences in their total numbers of 
neutrophils, lymphocytes, and leukocytes (Figure  3) further 
re-emphasizing the poor potential of assessing total immune cell 
numbers to predict the vulnerability of the immune system of 
HEU infants.
cOnclUsiOn
The present study contributes to the global effort to understand 
the immune determinants of HEU infants increased suscep-
tibility to infections during the first month of their life. Using 
NBT reduction assay, we found impaired oxidative burst in 
36% of HEU infants evaluated with no alteration in neutrophil 
counts suggesting that impaired neutrophils function could 
be one of the immune dysfunctions found in a number of 
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FigUre 3 | neutrophils, lymphocytes, and leukocytes counts of hiV-exposed uninfected infants. On the graphs, Infants (ROS+) indicate infants with normal 
reactive oxygen species (ROS) production, whereas Infants (ROS−) indicate infants with impaired ROS production.
HEU infants. The present results need to be validated in a larger 
study.
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